Work

Phase I Study of Stereotactic Body Radiotherapy followed by Ipilimumab with Nivolumab vs. Nivolumab alone in Unresectable Hepatocellular Carcinoma

Year: 2020

Type: article

Study design: Clinical Trial

Source: International Journal of Radiation Oncology*Biology*Physics

DOI: 10.1016/j.ijrobp.2020.07.900

Authors: A. Juloori, C.Y. Liao, J.M. Lemons, A.K. Singh, R. Iyer, J.R. Robbins, B. George, J. Fung, A. Pillai, F. Arif, M. Sharma, S. Liauw

Institutions: University of Chicago, University of Chicago Medical Center, Roswell Park Comprehensive Cancer Center, University of Arizona, Medical College of Wisconsin

Language: English

Topic: Hepatocellular Carcinoma Treatment and Prognosis

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3094521199

FWCI: 0.492

Cites:

Cited by: 5

Related to: 10